通过CD95（APO-I/Fas）受体-配体相互作用对细胞凋亡的调控。 - Suppr

Regulation of apoptosis through CD95 (APO-I/Fas) receptor-ligand interaction.

作者信息

Debatin K M, Beltinger C, Böhler T, Fellenberg J, Friesen C, Fulda S, Herr I, Los M, Scheuerpflug C, Sieverts H, Stahnke K

机构信息

University Children's Hospital, Heidelberg, Germany.

出版信息

Biochem Soc Trans. 1997 May;25(2):405-10. doi: 10.1042/bst0250405.

DOI:10.1042/bst0250405

PMID:9191126

Abstract

摘要

相似文献

Regulation of apoptosis through CD95 (APO-I/Fas) receptor-ligand interaction.

Biochem Soc Trans. 1997 May;25(2):405-10. doi: 10.1042/bst0250405.

Early work on the function of CD95, an interview with Shige Nagata.

Cell Death Differ. 2004 Jul;11 Suppl 1:S23-7. doi: 10.1038/sj.cdd.4401453.

The CD95(APO-1/Fas)/CD95L system.

Toxicol Lett. 1998 Dec 28;102-103:131-7. doi: 10.1016/s0378-4274(98)00297-5.

On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.

Leuk Lymphoma. 1998 Nov;31(5-6):477-90. doi: 10.3109/10428199809057607.

Cell death in T- and B-cell development.

Ann Hematol. 2001;80 Suppl 3:B29-31. doi: 10.1007/pl00022783.

Mutations in apoptosis genes: a pathogenetic factor for human disease.

Mutat Res. 2001 Jul;488(3):211-31. doi: 10.1016/s1383-5742(01)00057-6.

Apoptosis by death factor.

Cell. 1997 Feb 7;88(3):355-65. doi: 10.1016/s0092-8674(00)81874-7.

TNF receptor 2-deficient CD8 T cells are resistant to Fas/Fas ligand-induced cell death.

J Immunol. 2000 Nov 1;165(9):4814-21. doi: 10.4049/jimmunol.165.9.4814.

Mature T lymphocyte apoptosis in the healthy and diseased immune system.

Adv Exp Med Biol. 1996;406:229-39. doi: 10.1007/978-1-4899-0274-0_24.

Termination of antigen-specific immunity by CD95 ligand (Fas ligand) and IL-10.

J Immunol. 2004 Aug 1;173(3):1519-25. doi: 10.4049/jimmunol.173.3.1519.

引用本文的文献

Small Cell Lung Cancer-An Update on Chemotherapy Resistance.

Curr Treat Options Oncol. 2024 Aug;25(8):1112-1123. doi: 10.1007/s11864-024-01245-w. Epub 2024 Jul 27.

D4F alleviates macrophage-derived foam cell apoptosis by inhibiting the NF-κB-dependent Fas/FasL pathway.

Sci Rep. 2017 Aug 4;7(1):7333. doi: 10.1038/s41598-017-07656-0.

Anti-Tumorigenic Effects of Resveratrol in Lung Cancer Cells Through Modulation of c-FLIP.

Curr Cancer Drug Targets. 2017;17(7):669-680. doi: 10.2174/1568009617666170315162932.

Antioxidant c-FLIP inhibits Fas ligand-induced NF-kappaB activation in a phosphatidylinositol 3-kinase/Akt-dependent manner.

J Immunol. 2011 Sep 15;187(6):3256-66. doi: 10.4049/jimmunol.1002915. Epub 2011 Aug 19.

Stem cells for spinal cord regeneration: Current status.

Surg Neurol Int. 2010 Dec 25;1:93. doi: 10.4103/2152-7806.74240.

Up-regulation of Fas reverses cisplatin resistance of human small cell lung cancer cells.

J Exp Clin Cancer Res. 2010 May 14;29(1):49. doi: 10.1186/1756-9966-29-49.

Indomethacin-induced activation of the death receptor-mediated apoptosis pathway circumvents acquired doxorubicin resistance in SCLC cells.

Br J Cancer. 2005 Apr 25;92(8):1459-66. doi: 10.1038/sj.bjc.6602516.

Regulation of T-cell apoptosis: a mixed lymphocyte reaction model.

Immunology. 2000 Jul;100(3):289-99. doi: 10.1046/j.1365-2567.2000.00048.x.

Apoptosis and tumorigenesis in human cholangiocarcinoma cells. Involvement of Fas/APO-1 (CD95) and calmodulin.

Am J Pathol. 1999 Jul;155(1):193-203. doi: 10.1016/S0002-9440(10)65113-9.

Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis.

EMBO J. 1997 Oct 15;16(20):6200-8. doi: 10.1093/emboj/16.20.6200.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Regulation of apoptosis through CD95 (APO-I/Fas) receptor-ligand interaction.

作者信息

Debatin K M, Beltinger C, Böhler T, Fellenberg J, Friesen C, Fulda S, Herr I, Los M, Scheuerpflug C, Sieverts H, Stahnke K

机构信息

University Children's Hospital, Heidelberg, Germany.

出版信息

Biochem Soc Trans. 1997 May;25(2):405-10. doi: 10.1042/bst0250405.

DOI:10.1042/bst0250405

PMID:9191126

Abstract

摘要

相似文献

Regulation of apoptosis through CD95 (APO-I/Fas) receptor-ligand interaction.

Biochem Soc Trans. 1997 May;25(2):405-10. doi: 10.1042/bst0250405.

Early work on the function of CD95, an interview with Shige Nagata.

Cell Death Differ. 2004 Jul;11 Suppl 1:S23-7. doi: 10.1038/sj.cdd.4401453.

The CD95(APO-1/Fas)/CD95L system.

Toxicol Lett. 1998 Dec 28;102-103:131-7. doi: 10.1016/s0378-4274(98)00297-5.

On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.

Leuk Lymphoma. 1998 Nov;31(5-6):477-90. doi: 10.3109/10428199809057607.

Cell death in T- and B-cell development.

Ann Hematol. 2001;80 Suppl 3:B29-31. doi: 10.1007/pl00022783.

Mutations in apoptosis genes: a pathogenetic factor for human disease.

Mutat Res. 2001 Jul;488(3):211-31. doi: 10.1016/s1383-5742(01)00057-6.

Apoptosis by death factor.

Cell. 1997 Feb 7;88(3):355-65. doi: 10.1016/s0092-8674(00)81874-7.

TNF receptor 2-deficient CD8 T cells are resistant to Fas/Fas ligand-induced cell death.

J Immunol. 2000 Nov 1;165(9):4814-21. doi: 10.4049/jimmunol.165.9.4814.

Mature T lymphocyte apoptosis in the healthy and diseased immune system.

Adv Exp Med Biol. 1996;406:229-39. doi: 10.1007/978-1-4899-0274-0_24.

Termination of antigen-specific immunity by CD95 ligand (Fas ligand) and IL-10.

J Immunol. 2004 Aug 1;173(3):1519-25. doi: 10.4049/jimmunol.173.3.1519.

引用本文的文献

Small Cell Lung Cancer-An Update on Chemotherapy Resistance.

Curr Treat Options Oncol. 2024 Aug;25(8):1112-1123. doi: 10.1007/s11864-024-01245-w. Epub 2024 Jul 27.

D4F alleviates macrophage-derived foam cell apoptosis by inhibiting the NF-κB-dependent Fas/FasL pathway.

Sci Rep. 2017 Aug 4;7(1):7333. doi: 10.1038/s41598-017-07656-0.

Anti-Tumorigenic Effects of Resveratrol in Lung Cancer Cells Through Modulation of c-FLIP.

Curr Cancer Drug Targets. 2017;17(7):669-680. doi: 10.2174/1568009617666170315162932.

Antioxidant c-FLIP inhibits Fas ligand-induced NF-kappaB activation in a phosphatidylinositol 3-kinase/Akt-dependent manner.

J Immunol. 2011 Sep 15;187(6):3256-66. doi: 10.4049/jimmunol.1002915. Epub 2011 Aug 19.

Stem cells for spinal cord regeneration: Current status.

Surg Neurol Int. 2010 Dec 25;1:93. doi: 10.4103/2152-7806.74240.

Up-regulation of Fas reverses cisplatin resistance of human small cell lung cancer cells.

J Exp Clin Cancer Res. 2010 May 14;29(1):49. doi: 10.1186/1756-9966-29-49.

Indomethacin-induced activation of the death receptor-mediated apoptosis pathway circumvents acquired doxorubicin resistance in SCLC cells.

Br J Cancer. 2005 Apr 25;92(8):1459-66. doi: 10.1038/sj.bjc.6602516.

Regulation of T-cell apoptosis: a mixed lymphocyte reaction model.

Immunology. 2000 Jul;100(3):289-99. doi: 10.1046/j.1365-2567.2000.00048.x.

Apoptosis and tumorigenesis in human cholangiocarcinoma cells. Involvement of Fas/APO-1 (CD95) and calmodulin.

Am J Pathol. 1999 Jul;155(1):193-203. doi: 10.1016/S0002-9440(10)65113-9.

Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis.

EMBO J. 1997 Oct 15;16(20):6200-8. doi: 10.1093/emboj/16.20.6200.

Regulation of apoptosis through CD95 (APO-I/Fas) receptor-ligand interaction.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Regulation of apoptosis through CD95 (APO-I/Fas) receptor-ligand interaction.

作者信息

机构信息

出版信息

相似文献

引用本文的文献